DOCK4 and neoplasm: DOCK4 expression was initially assessed in a local breast tumour array of 345 unselected breast tumours (88% ductal, 9% lobular, 3% other) with patient data available on tumour grade (18% grade 1, 44% grade 2, 38% grade 3), ER and axillary lymph node involvement.